Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 257

1.

Loratadine provides early symptom control in seasonal allergic rhinitis.

Kaiser HB, Gopalan G, Chung W.

Allergy Asthma Proc. 2008 Nov-Dec;29(6):654-8. doi: 10.2500/aap.2008.29.3166. Epub 2008 Oct 1.

PMID:
18831859
4.
5.

Clinical benefits of combination treatment with mometasone furoate nasal spray and loratadine vs monotherapy with mometasone furoate in the treatment of seasonal allergic rhinitis.

Anolik R; Mometasone Furoate Nasal Spray With Loratadine Study Group.

Ann Allergy Asthma Immunol. 2008 Mar;100(3):264-71. doi: 10.1016/S1081-1206(10)60452-8.

PMID:
18426147
6.

Comparison of the combinations of fexofenadine-pseudoephedrine and loratadine-montelukast in the treatment of seasonal allergic rhinitis.

Moinuddin R, deTineo M, Maleckar B, Naclerio RM, Baroody FM.

Ann Allergy Asthma Immunol. 2004 Jan;92(1):73-9.

PMID:
14756468
7.
8.

Safety and efficacy of once-daily fexofenadine HCl in the treatment of autumn seasonal allergic rhinitis.

Casale TB, Andrade C, Qu R.

Allergy Asthma Proc. 1999 May-Jun;20(3):193-8.

PMID:
10389553
10.

Fexofenadine hydrochloride, 180 mg, exhibits equivalent efficacy to cetirizine, 10 mg, with less drowsiness in patients with moderate-to-severe seasonal allergic rhinitis.

Hampel F, Ratner P, Mansfield L, Meeves S, Liao Y, Georges G.

Ann Allergy Asthma Immunol. 2003 Oct;91(4):354-61.

PMID:
14582814
11.

Onset of action of loratadine/montelukast in seasonal allergic rhinitis patients exposed to grass pollen.

Horak F, Zieglmayer P, Zieglmayer R, Lemell P.

Arzneimittelforschung. 2010;60(5):249-55.

PMID:
20533761
12.

Onset of action of loratadine/montelukast in seasonal allergic rhinitis subjects exposed to ragweed pollen in the Environmental Exposure Unit.

Day JH, Briscoe MP, Ratz JD, Ellis AK, Yao R, Danzig M.

Allergy Asthma Proc. 2009 May-Jun;30(3):270-6. doi: 10.2500/aap.2009.30.3234.

PMID:
19549428
13.

Efficacy and safety of fixed-dose loratadine/montelukast in seasonal allergic rhinitis: effects on nasal congestion.

Prenner B, Anolik R, Danzig M, Yao R.

Allergy Asthma Proc. 2009 May-Jun;30(3):263-9. doi: 10.2500/aap.2009.30.3228.

PMID:
19549427
15.
16.

Comparative efficacy and safety of a once-daily loratadine-pseudoephedrine combination versus its components alone and placebo in the management of seasonal allergic rhinitis.

Bronsky E, Boggs P, Findlay S, Gawchik S, Georgitis J, Mansmann H, Sholler L, Wolfe J, Meltzer E, Morris R, et al.

J Allergy Clin Immunol. 1995 Aug;96(2):139-47.

PMID:
7636050
17.

Efficacy of desloratadine, 5 mg, compared with fexofenadine, 180 mg, in patients with symptomatic seasonal allergic rhinitis.

Berger WE, Lumry WR, Meltzer EO, Pearlman DS.

Allergy Asthma Proc. 2006 May-Jun;27(3):214-23.

PMID:
16913264
18.
19.

Comparative efficacy and safety of once-daily versus twice-daily loratadine-pseudoephedrine combinations versus placebo in seasonal allergic rhinitis.

Kaiser HB, Banov CH, Berkowitz RR, Bernstein DI, Bronsky EA, Georgitis JW, Mendelson LM, Rooklin AR, Sholler LJ, Stricker WW, Harrison JE, Danzig MR, Lorber RR.

Am J Ther. 1998 Jul;5(4):245-51.

PMID:
10099066
20.
Items per page

Supplemental Content

Write to the Help Desk